United States Biotechnology & Medical Research

TetraLogic Pharmaceuticals Corp (TLOG)

Track

Track

Ticker: TLOG Exchange: OTC
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Clarus Lifesciences II, L.P. Large shareholder
Transaction date
Sale
Price
229.08
Quantity 88,144 +10.2%
Value US$4,643,011
Clarus Lifesciences II, L.P. Large shareholder
Transaction date
Sale
Price
102.79
Quantity 92,490 +35.2%
Value US$2,616,298
Clarus Lifesciences II, L.P. Large shareholder
Transaction date
Sale
Price
183.12
Quantity 5,513 -1.8%
Value US$4,222,676
Clarus Lifesciences II, L.P. Large shareholder
Transaction date
Sale
Price
0.14
Quantity 500,026 -12.9%
Value US$70,004
Clarus Lifesciences II, L.P. Large shareholder
Transaction date
Sale
Price
0.15
Quantity 82,583 -2.1%
Value US$12,387
Clarus Lifesciences II, L.P. Large shareholder
Transaction date
Sale
Price
0.17
Quantity 176,306 -4.3%
Value US$29,972
Clarus Lifesciences II, L.P. Large shareholder
Transaction date
Sale
Price
0.20
Quantity 140,000 -3.3%
Value US$28,000
Clarus Lifesciences II, L.P. Large shareholder
Transaction date
Sale
Price
0.26
Quantity 52,826 -1.2%
Value US$13,735
Clarus Lifesciences II, L.P. Large shareholder
Transaction date
Sale
Price
0.26
Quantity 32,521 -0.7%
Value US$8,455
Clarus Lifesciences II, L.P. Large shareholder
Transaction date
Sale
Price
0.27
Quantity 209,984 -4.6%
Value US$56,696
Clarus Lifesciences II, L.P. Large shareholder
Transaction date
Sale
Price
0.30
Quantity 69,425 -1.5%
Value US$20,828
Pecora Andrew L Non-Executive Director
Transaction date
Purchase
Price
2.79
Quantity 9,200 +5.2%
Value US$25,668
Pecora Andrew L Non-Executive Director
Transaction date
Purchase
Price
2.75
Quantity 800 +0.5%
Value US$2,200
Pecora Andrew L Non-Executive Director
Transaction date
Purchase
Price
2.75
Quantity 7,608 +4.5%
Value US$20,884
Pecora Andrew L Non-Executive Director
Transaction date
Purchase
Price
2.74
Quantity 6,900 +4.3%
Value US$18,927
Pecora Andrew L Non-Executive Director
Transaction date
Purchase
Price
2.74
Quantity 10,000 +6.7%
Value US$27,370
Pecora Andrew L Non-Executive Director
Transaction date
Purchase
Price
2.69
Quantity 2,100 +1.4%
Value US$5,649
Pecora Andrew L Non-Executive Director
Transaction date
Purchase
Price
2.66
Quantity 908 +0.6%
Value US$2,414
Pecora Andrew L Non-Executive Director
Transaction date
Purchase
Price
2.65
Quantity 1,092 +0.7%
Value US$2,894
Pecora Andrew L Non-Executive Director
Transaction date
Purchase
Price
2.57
Quantity 92 +0.1%
Value US$236
Pecora Andrew L Non-Executive Director
Transaction date
Purchase
Price
2.54
Quantity 1,300 +0.9%
Value US$3,302
Pecora Andrew L Non-Executive Director
Transaction date
Purchase
Price
2.44
Quantity 10,000 +7.4%
Value US$24,400
Pecora Andrew L Non-Executive Director
Transaction date
Purchase
Price
2.41
Quantity 10,000 +8.0%
Value US$24,090
Pecora Andrew L Non-Executive Director
Transaction date
Purchase
Price
2.40
Quantity 40,000 +47.2%
Value US$96,000
Schmitt Paul J Non-Executive Director
Transaction date
Purchase
Price
2.34
Quantity 6,500 +48.1%
Value US$15,188
Schmitt Paul J Non-Executive Director
Transaction date
Purchase
Price
2.33
Quantity 3,500 +35.0%
Value US$8,169
Meyers Pete A. CFO & Treasurer Officer
Transaction date
Purchase
Price
4.35
Quantity 5,000 +3.4%
Value US$21,750
BUCHI J KEVIN President & CEO Executive Director
Transaction date
Purchase
Price
4.23
Quantity 5,000 +1.5%
Value US$21,148
BUCHI J KEVIN President & CEO Executive Director
Transaction date
Purchase
Price
5.04
Quantity 5,000 +1.6%
Value US$25,181
Begley Colin Glenn Chief Scientific Officer & SVP Officer
Transaction date
Purchase
Price
6.16
Quantity 5,900 +3.1%
Value US$36,344
BUCHI J KEVIN President & CEO Executive Director
Transaction date
Purchase
Price
6.01
Quantity 5,000 +1.6%
Value US$30,060
Meyers Pete A. CFO & Treasurer Officer
Transaction date
Purchase
Price
4.94
Quantity 1,034 +0.7%
Value US$5,108
BUCHI J KEVIN President & CEO Executive Director
Transaction date
Purchase
Price
4.99
Quantity 10,000 +3.3%
Value US$49,900
Begley Colin Glenn Chief Scientific Officer & SVP Officer
Transaction date
Purchase
Price
4.87
Quantity 1,100 +inf%
Value US$5,352
Begley Colin Glenn Chief Scientific Officer & SVP Officer
Transaction date
Purchase
Price
4.90
Quantity 1,000 +0.5%
Value US$4,900
Russell Lesley Chief Operating Officer Officer
Transaction date
Purchase
Price
4.90
Quantity 20,000 +inf%
Value US$97,970
Begley Colin Glenn Chief Scientific Officer & SVP Officer
Transaction date
Purchase
Price
4.81
Quantity 1,000 +0.5%
Value US$4,810
Begley Colin Glenn Chief Scientific Officer & SVP Officer
Transaction date
Purchase
Price
4.84
Quantity 100 +0.1%
Value US$484
Begley Colin Glenn Chief Scientific Officer & SVP Officer
Transaction date
Purchase
Price
4.84
Quantity 200 +0.1%
Value US$968
Begley Colin Glenn Chief Scientific Officer & SVP Officer
Transaction date
Purchase
Price
4.85
Quantity 500 +0.3%
Value US$2,424
Begley Colin Glenn Chief Scientific Officer & SVP Officer
Transaction date
Purchase
Price
4.85
Quantity 500 +0.3%
Value US$2,422
Begley Colin Glenn Chief Scientific Officer & SVP Officer
Transaction date
Purchase
Price
4.87
Quantity 700 +0.4%
Value US$3,409
BUCHI J KEVIN President & CEO Executive Director
Transaction date
Purchase
Price
4.82
Quantity 10,000 +3.4%
Value US$48,185
Pecora Andrew L Non-Executive Director
Transaction date
Purchase
Price
4.53
Quantity 20,000 +30.8%
Value US$90,640
Meyers Peter A. CFO & Treasurer Officer
Transaction date
Purchase
Price
3.98
Quantity 5,000 +3.5%
Value US$19,890
BUCHI J KEVIN President and CEO Executive Director
Transaction date
Purchase
Price
3.93
Quantity 10,000 +3.5%
Value US$39,325
Schmitt Paul J Non-Executive Director
Transaction date
Purchase
Price
4.14
Quantity 10,000 +inf%
Value US$41,352
Schmitt Paul J Non-Executive Director
Transaction date
Purchase
Price
4.06
Quantity 10,000 +inf%
Value US$40,630
Woody James N. Non-Executive Director
Transaction date
Purchase
Price
7.00
Quantity 6,079 +2.4%
Value US$42,553
Woody James N. Non-Executive Director
Transaction date
Purchase
Price
7.00
Quantity 12,159 +5.0%
Value US$85,113
Woody James N. Non-Executive Director
Transaction date
Purchase
Price
7.00
Quantity 243,189 +inf%
Value US$1,702,323
Clarus Lifesciences II, L.P. Large shareholder
Transaction date
Purchase
Price
7.00
Quantity 1,425,063 +inf%
Value US$9,975,441
BUCHI J KEVIN President and CEO Executive Director
Transaction date
Purchase
Price
7.00
Quantity 285,714 +inf%
Value US$1,999,998
Pecora Andrew L Non-Executive Director
Transaction date
Purchase
Price
7.00
Quantity 26,551 +164.1%
Value US$185,857
Meyers Peter A. CFO & Treasurer Officer
Transaction date
Purchase
Price
7.00
Quantity 142,857 +inf%
Value US$999,999
Schmitt Paul J Non-Executive Director
Transaction date
Purchase
Price
7.00
Quantity 445,179 +inf%
Value US$3,116,253
Reed Douglas MD Non-Executive Director
Transaction date
Purchase
Price
7.00
Quantity 142,857 +inf%
Value US$999,999
AMGEN INC Large shareholder
Transaction date
Purchase
Price
7.00
Quantity 272,142 +101.1%
Value US$1,904,994
HEALTHCARE VENTURES VII LP Large shareholder
Transaction date
Purchase
Price
7.00
Quantity 713,463 +38.1%
Value US$4,994,241
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2016-02-10 2016-02-09 S Sale Clarus Lifesciences II, L.P. Large shareholder
88,144 +10.2%
229.08
US$4,643,011 		88,144 +10.2% 229.08 US$4,643,011
2016-02-10 2016-02-08 S Sale Clarus Lifesciences II, L.P. Large shareholder
92,490 +35.2%
102.79
US$2,616,298 		92,490 +35.2% 102.79 US$2,616,298
2016-02-05 2016-02-05 S Sale Clarus Lifesciences II, L.P. Large shareholder
5,513 -1.8%
183.12
US$4,222,676 		5,513 -1.8% 183.12 US$4,222,676
2016-02-05 2016-02-04 S Sale Clarus Lifesciences II, L.P. Large shareholder
500,026 -12.9%
0.14
US$70,004 		500,026 -12.9% 0.14 US$70,004
2016-02-05 2016-02-03 S Sale Clarus Lifesciences II, L.P. Large shareholder
82,583 -2.1%
0.15
US$12,387 		82,583 -2.1% 0.15 US$12,387
2016-02-02 2016-02-02 S Sale Clarus Lifesciences II, L.P. Large shareholder
176,306 -4.3%
0.17
US$29,972 		176,306 -4.3% 0.17 US$29,972
2016-02-02 2016-02-01 S Sale Clarus Lifesciences II, L.P. Large shareholder
140,000 -3.3%
0.20
US$28,000 		140,000 -3.3% 0.20 US$28,000
2016-02-02 2016-01-29 S Sale Clarus Lifesciences II, L.P. Large shareholder
52,826 -1.2%
0.26
US$13,735 		52,826 -1.2% 0.26 US$13,735
2016-01-28 2016-01-28 S Sale Clarus Lifesciences II, L.P. Large shareholder
32,521 -0.7%
0.26
US$8,455 		32,521 -0.7% 0.26 US$8,455
2016-01-28 2016-01-27 S Sale Clarus Lifesciences II, L.P. Large shareholder
209,984 -4.6%
0.27
US$56,696 		209,984 -4.6% 0.27 US$56,696
2016-01-28 2016-01-26 S Sale Clarus Lifesciences II, L.P. Large shareholder
69,425 -1.5%
0.30
US$20,828 		69,425 -1.5% 0.30 US$20,828
2015-07-14 2015-07-10 B Purchase Pecora Andrew L Non-Executive Director
9,200 +5.2%
2.79
US$25,668 		9,200 +5.2% 2.79 US$25,668
2015-07-14 2015-07-10 B Purchase Pecora Andrew L Non-Executive Director
800 +0.5%
2.75
US$2,200 		800 +0.5% 2.75 US$2,200
2015-07-14 2015-07-10 B Purchase Pecora Andrew L Non-Executive Director
7,608 +4.5%
2.75
US$20,884 		7,608 +4.5% 2.75 US$20,884
2015-07-14 2015-07-10 B Purchase Pecora Andrew L Non-Executive Director
6,900 +4.3%
2.74
US$18,927 		6,900 +4.3% 2.74 US$18,927
2015-07-14 2015-07-10 B Purchase Pecora Andrew L Non-Executive Director
10,000 +6.7%
2.74
US$27,370 		10,000 +6.7% 2.74 US$27,370
2015-07-14 2015-07-10 B Purchase Pecora Andrew L Non-Executive Director
2,100 +1.4%
2.69
US$5,649 		2,100 +1.4% 2.69 US$5,649
2015-07-14 2015-07-10 B Purchase Pecora Andrew L Non-Executive Director
908 +0.6%
2.66
US$2,414 		908 +0.6% 2.66 US$2,414
2015-07-14 2015-07-10 B Purchase Pecora Andrew L Non-Executive Director
1,092 +0.7%
2.65
US$2,894 		1,092 +0.7% 2.65 US$2,894
2015-07-14 2015-07-10 B Purchase Pecora Andrew L Non-Executive Director
92 +0.1%
2.57
US$236 		92 +0.1% 2.57 US$236
2015-07-14 2015-07-10 B Purchase Pecora Andrew L Non-Executive Director
1,300 +0.9%
2.54
US$3,302 		1,300 +0.9% 2.54 US$3,302
2015-07-14 2015-07-10 B Purchase Pecora Andrew L Non-Executive Director
10,000 +7.4%
2.44
US$24,400 		10,000 +7.4% 2.44 US$24,400
2015-07-13 2015-07-09 B Purchase Pecora Andrew L Non-Executive Director
10,000 +8.0%
2.41
US$24,090 		10,000 +8.0% 2.41 US$24,090
2015-07-13 2015-07-09 B Purchase Pecora Andrew L Non-Executive Director
40,000 +47.2%
2.40
US$96,000 		40,000 +47.2% 2.40 US$96,000
2015-07-06 2015-07-02 B Purchase Schmitt Paul J Non-Executive Director
6,500 +48.1%
2.34
US$15,188 		6,500 +48.1% 2.34 US$15,188
2015-07-06 2015-07-02 B Purchase Schmitt Paul J Non-Executive Director
3,500 +35.0%
2.33
US$8,169 		3,500 +35.0% 2.33 US$8,169
2015-03-31 2015-03-27 B Purchase Meyers Pete A.

CFO & Treasurer

Officer
5,000 +3.4%
4.35
US$21,750 		5,000 +3.4% 4.35 US$21,750
2015-03-30 2015-03-26 B Purchase BUCHI J KEVIN

President & CEO

Executive Director
5,000 +1.5%
4.23
US$21,148 		5,000 +1.5% 4.23 US$21,148
2015-01-09 2015-01-07 B Purchase BUCHI J KEVIN

President & CEO

Executive Director
5,000 +1.6%
5.04
US$25,181 		5,000 +1.6% 5.04 US$25,181
2014-12-12 2014-12-10 B Purchase Begley Colin Glenn

Chief Scientific Officer & SVP

Officer
5,900 +3.1%
6.16
US$36,344 		5,900 +3.1% 6.16 US$36,344
2014-12-11 2014-12-09 B Purchase BUCHI J KEVIN

President & CEO

Executive Director
5,000 +1.6%
6.01
US$30,060 		5,000 +1.6% 6.01 US$30,060
2014-12-08 2014-12-04 B Purchase Meyers Pete A.

CFO & Treasurer

Officer
1,034 +0.7%
4.94
US$5,108 		1,034 +0.7% 4.94 US$5,108
2014-12-04 2014-12-02 B Purchase BUCHI J KEVIN

President & CEO

Executive Director
10,000 +3.3%
4.99
US$49,900 		10,000 +3.3% 4.99 US$49,900
2014-12-01 2014-11-26 B Purchase Begley Colin Glenn

Chief Scientific Officer & SVP

Officer
1,100 +inf%
4.87
US$5,352 		1,100 +inf% 4.87 US$5,352
2014-12-01 2014-11-26 B Purchase Begley Colin Glenn

Chief Scientific Officer & SVP

Officer
1,000 +0.5%
4.90
US$4,900 		1,000 +0.5% 4.90 US$4,900
2014-12-01 2014-11-26 B Purchase Russell Lesley

Chief Operating Officer

Officer
20,000 +inf%
4.90
US$97,970 		20,000 +inf% 4.90 US$97,970
2014-12-01 2014-11-26 B Purchase Begley Colin Glenn

Chief Scientific Officer & SVP

Officer
1,000 +0.5%
4.81
US$4,810 		1,000 +0.5% 4.81 US$4,810
2014-11-28 2014-11-25 B Purchase Begley Colin Glenn

Chief Scientific Officer & SVP

Officer
100 +0.1%
4.84
US$484 		100 +0.1% 4.84 US$484
2014-11-28 2014-11-25 B Purchase Begley Colin Glenn

Chief Scientific Officer & SVP

Officer
200 +0.1%
4.84
US$968 		200 +0.1% 4.84 US$968
2014-11-28 2014-11-25 B Purchase Begley Colin Glenn

Chief Scientific Officer & SVP

Officer
500 +0.3%
4.85
US$2,424 		500 +0.3% 4.85 US$2,424
2014-11-28 2014-11-25 B Purchase Begley Colin Glenn

Chief Scientific Officer & SVP

Officer
500 +0.3%
4.85
US$2,422 		500 +0.3% 4.85 US$2,422
2014-11-28 2014-11-25 B Purchase Begley Colin Glenn

Chief Scientific Officer & SVP

Officer
700 +0.4%
4.87
US$3,409 		700 +0.4% 4.87 US$3,409
2014-11-20 2014-11-18 B Purchase BUCHI J KEVIN

President & CEO

Executive Director
10,000 +3.4%
4.82
US$48,185 		10,000 +3.4% 4.82 US$48,185
2014-11-19 2014-11-17 B Purchase Pecora Andrew L Non-Executive Director
20,000 +30.8%
4.53
US$90,640 		20,000 +30.8% 4.53 US$90,640
2014-11-13 2014-11-12 B Purchase Meyers Peter A.

CFO & Treasurer

Officer
5,000 +3.5%
3.98
US$19,890 		5,000 +3.5% 3.98 US$19,890
2014-11-13 2014-11-11 B Purchase BUCHI J KEVIN

President and CEO

Executive Director
10,000 +3.5%
3.93
US$39,325 		10,000 +3.5% 3.93 US$39,325
2014-11-12 2014-11-10 B Purchase Schmitt Paul J Non-Executive Director
10,000 +inf%
4.14
US$41,352 		10,000 +inf% 4.14 US$41,352
2014-11-12 2014-11-10 B Purchase Schmitt Paul J Non-Executive Director
10,000 +inf%
4.06
US$40,630 		10,000 +inf% 4.06 US$40,630
2013-12-19 2013-12-17 B Purchase Woody James N. Non-Executive Director
6,079 +2.4%
7.00
US$42,553 		6,079 +2.4% 7.00 US$42,553
2013-12-19 2013-12-17 B Purchase Woody James N. Non-Executive Director
12,159 +5.0%
7.00
US$85,113 		12,159 +5.0% 7.00 US$85,113
2013-12-19 2013-12-17 B Purchase Woody James N. Non-Executive Director
243,189 +inf%
7.00
US$1,702,323 		243,189 +inf% 7.00 US$1,702,323
2013-12-19 2013-12-17 B Purchase Clarus Lifesciences II, L.P. Large shareholder
1,425,063 +inf%
7.00
US$9,975,441 		1,425,063 +inf% 7.00 US$9,975,441
2013-12-19 2013-12-17 B Purchase BUCHI J KEVIN

President and CEO

Executive Director
285,714 +inf%
7.00
US$1,999,998 		285,714 +inf% 7.00 US$1,999,998
2013-12-19 2013-12-17 B Purchase Pecora Andrew L Non-Executive Director
26,551 +164.1%
7.00
US$185,857 		26,551 +164.1% 7.00 US$185,857
2013-12-19 2013-12-17 B Purchase Meyers Peter A.

CFO & Treasurer

Officer
142,857 +inf%
7.00
US$999,999 		142,857 +inf% 7.00 US$999,999
2013-12-19 2013-12-17 B Purchase Schmitt Paul J Non-Executive Director
445,179 +inf%
7.00
US$3,116,253 		445,179 +inf% 7.00 US$3,116,253
2013-12-19 2013-12-17 B Purchase Reed Douglas MD Non-Executive Director
142,857 +inf%
7.00
US$999,999 		142,857 +inf% 7.00 US$999,999
2013-12-18 2013-12-17 B Purchase AMGEN INC Large shareholder
272,142 +101.1%
7.00
US$1,904,994 		272,142 +101.1% 7.00 US$1,904,994
2013-12-17 2013-12-17 B Purchase HEALTHCARE VENTURES VII LP Large shareholder
713,463 +38.1%
7.00
US$4,994,241 		713,463 +38.1% 7.00 US$4,994,241
Explore more

More insider trading research around TetraLogic Pharmaceuticals Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America